Cargando…

Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma

BACKGROUND: Diagnosing immune checkpoint inhibitor (ICI)-associated nephritis can be challenging since it is a rare complication of therapy, associated with a spectrum of immune-mediated pathologies, and can present months after ICI therapy discontinuation (i.e., late-onset). ICIs are increasingly a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ratanasrimetha, Praveen, Reddy, Vikas D., Kala, Jaya, Tchakarov, Amanda, Glass, William F., Msaouel, Pavlos, Lin, Jamie S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366044/ https://www.ncbi.nlm.nih.gov/pubmed/35967405 http://dx.doi.org/10.3389/fimmu.2022.898811

Ejemplares similares

Checkpoint inhibitor-related renal vasculitis and use of rituximab
por: Mamlouk, Omar, et al.
Publicado: (2020)

Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab
por: Lin, Jamie S, et al.
Publicado: (2020)

Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab
por: Qureshi, Sehrish, et al.
Publicado: (2023)

Infliximab for the treatment of patients with checkpoint inhibitor–associated acute tubular interstitial nephritis
por: Lin, Jamie S., et al.
Publicado: (2021)

The Influence of Obesity on Outcomes with Immune Checkpoint Blockade: Clinical Evidence and Potential Biological Mechanisms
por: Hahn, Andrew W., et al.
Publicado: (2023)

Successful treatment of late onset post-phacoemulsification Descemet’s membrane detachment
por: Kocak Altintas, Ayse Gul, et al.
Publicado: (2019)

Membranous Nephropathy After Exposure to Immune Checkpoint Inhibitors
por: Benyahia, Rayane, et al.
Publicado: (2023)

Pathologic Predictors of Response to Treatment of Immune Checkpoint Inhibitor–Induced Kidney Injury
por: Abudayyeh, Ala, et al.
Publicado: (2022)

Urinary T cells are detected in patients with immune checkpoint inhibitor-associated immune nephritis that are clonotypically identical to kidney T cell infiltrates
por: Singh, Shailbala, et al.
Publicado: (2022)

Membranous nephropathy in chronic lymphocytic leukemia responsive to ibrutinib: A case report
por: Turcotte, Anna-Eve, et al.
Publicado: (2023)

Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
por: Mamlouk, Omar, et al.
Publicado: (2019)

Impact of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Renal Function in Chronic Kidney Disease Patients Undergoing Coronary Angiography
por: Motes, Arunee T, et al.
Publicado: (2021)

Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis
por: Msaouel, Pavlos, et al.
Publicado: (2011)

Successful management of late-onset Streptococcus mitis endophthalmitis
por: Chon, Jinmann, et al.
Publicado: (2017)

Early-onset liver mtDNA depletion and late-onset proteinuric nephropathy in Mpv17 knockout mice
por: Viscomi, Carlo, et al.
Publicado: (2009)

2105. Early-onset and Late-onset BK Polyomavirus-associated Nephropathy: A 10-year Retrospective Analysis
por: Thiandech, Vichitra, et al.
Publicado: (2022)

Case report: Successful treatment of refractory membranous nephropathy with telitacicept
por: Zhang, Lei, et al.
Publicado: (2023)

Molecular hallmarks of renal medullary carcinoma: more to c-MYC than meets the eye
por: Msaouel, Pavlos, et al.
Publicado: (2020)

Late-Onset Immunotherapy-Induced Myocarditis 2 Years After Checkpoint Inhibitor Initiation
por: Nguyen, Andrew T., et al.
Publicado: (2022)

Relapsing minimal change disease superimposed on late-onset p.N215S Fabry nephropathy
por: Salerno, Fabio R, et al.
Publicado: (2021)

Spermatozoal sensitive biomarkers to defective protaminosis and fragmented DNA
por: Angelopoulou, Roxani, et al.
Publicado: (2007)

Targeting proteostasis and autophagy in SMARCB1-deficient malignancies: where next?
por: Msaouel, Pavlos, et al.
Publicado: (2019)

Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas
por: Alhalabi, Omar, et al.
Publicado: (2023)

Durvalumab-associated Late-onset Myocarditis Successfully Treated with Corticosteroid Therapy
por: Maetani, Tomoki, et al.
Publicado: (2021)

Late-Onset Giant Cell Myocarditis Due to Enterovirus During Treatment With Immune Checkpoint Inhibitors
por: Mirabel, Mariana, et al.
Publicado: (2020)

A Case of Lung Cancer with Very-Late-Onset Immune Checkpoint Inhibitor-Related Myocarditis
por: Nishikawa, Tatsuya, et al.
Publicado: (2022)

THU353 Late Onset Of Immune Checkpoint Inhibitor-Related Diabetes After 3 Years
por: Avula, Sreekant, et al.
Publicado: (2023)

Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy
por: Chen, Xinxin, et al.
Publicado: (2017)

Membranous Nephropathy
por: Mathieson, Peter
Publicado: (1997)

Membranous nephropathy
por: Dantas, Márcio, et al.
Publicado: (2023)

The role of the insulin-like growth factor-1 system in breast cancer
por: Christopoulos, Panagiotis F, et al.
Publicado: (2015)

Making Patient-Specific Treatment Decisions Using Prognostic Variables and Utilities of Clinical Outcomes
por: Msaouel, Pavlos, et al.
Publicado: (2021)

Missing the trees for the forest: most subgroup analyses using forest plots at the ASCO annual meeting are inconclusive
por: Hahn, Andrew W., et al.
Publicado: (2022)

Interpreting Randomized Controlled Trials
por: Msaouel, Pavlos, et al.
Publicado: (2023)

Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy
por: Salerno, Fabio R, et al.
Publicado: (2022)

Late-onset cytomegalovirus pneumonitis successfully treated by cytomegalovirus immunoglobulin in heart transplant patient with renal failure
por: Jaksic Jurinjak, Sandra, et al.
Publicado: (2021)

Membranous Nephropathy with Proteinase 3-ANCA-associated Vasculitis Successfully Treated with Rituximab
por: Yoshida, Shun, et al.
Publicado: (2020)

PHENOMENOLOGICAL STUDY OF LATE-ONSET SCHIZOPHRENIA
por: Harish, M.G., et al.
Publicado: (1996)

A case of membranous nephropathy diagnosed with lupus nephritis 11 years after onset
por: Yamada, Takehisa, et al.
Publicado: (2019)

Recurrent idiopathic membranous nephropathy in the renal allograft: successful treatment with the anti-CD20 monoclonal antibody rituximab
por: Ladino, Marco, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_bgsl7sqgpvmege7f0070asr9ms